Search research articles
Contact Us
Filters
Showing results (51-60 of 73) with videos related to
Page
of 8
Sort By:
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
April 6, 2016
Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project
Àngels Betriu, Cristina Farràs, María Abajo, et al.
BMC Nephrology
|
March 26, 2021
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
José Luis Gorriz, David Arroyo, Luis D'Marco, et al.
AIDS Research and Human Retroviruses
|
June 11, 2015
The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age
José-Ramón Blanco, David Arroyo-Manzano, John F Rojas-Liévano, et al.
Metabolites
|
November 25, 2021
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study
Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, et al.
Antiviral Research
|
May 16, 2015
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes
Josep M Llibre, Antonio Rivero, Jhon F Rojas, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social
|
November 15, 2022
[PCR for COVID in the transplant protocol]
Esmeralda Campos-Aguirre, Julio César Martínez-Álvarez, María Araceli Arrazola-García, et al.
Expert Opinion on Therapeutic Targets
|
May 18, 2019
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Marcelino Bermudez-Lopez, Carles Forne, Nuria Amigo, et al.
Journal of Clinical Medicine
|
May 13, 2023
Diagnosis and Management of Malnutrition in Patients with Heart Failure
Alberto Esteban-Fernández, Rocío Villar-Taibo, Mirian Alejo, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2017
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis
Agustín Albillos, Javier Zamora, Javier Martínez, et al.
Cardiovascular Drugs and Therapy
|
June 27, 2018
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)
Marian Goicoechea, Soledad García de Vinuesa, Borja Quiroga, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 73) with videos related to
Sort By:
Page
of 8
Nefrologia : Publicacion Oficial De La Sociedad Espanola Nefrologia
|
April 6, 2016
Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project
Àngels Betriu, Cristina Farràs, María Abajo, et al.
BMC Nephrology
|
March 26, 2021
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease
José Luis Gorriz, David Arroyo, Luis D'Marco, et al.
AIDS Research and Human Retroviruses
|
June 11, 2015
The efficacy and safety of maraviroc addition to a stable antiretroviral regimen in subjects with suppressed plasma HIV-RNA is not influenced by age
José-Ramón Blanco, David Arroyo-Manzano, John F Rojas-Liévano, et al.
Metabolites
|
November 25, 2021
Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study
Patricia Muñoz Ramos, Yohana Gil Giraldo, Vicente Álvarez-Chiva, et al.
Antiviral Research
|
May 16, 2015
Safety, efficacy and indications of prescription of maraviroc in clinical practice: Factors associated with clinical outcomes
Josep M Llibre, Antonio Rivero, Jhon F Rojas, et al.
Revista Medica Del Instituto Mexicano Del Seguro Social
|
November 15, 2022
[PCR for COVID in the transplant protocol]
Esmeralda Campos-Aguirre, Julio César Martínez-Álvarez, María Araceli Arrazola-García, et al.
Expert Opinion on Therapeutic Targets
|
May 18, 2019
An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients
Marcelino Bermudez-Lopez, Carles Forne, Nuria Amigo, et al.
Journal of Clinical Medicine
|
May 13, 2023
Diagnosis and Management of Malnutrition in Patients with Heart Failure
Alberto Esteban-Fernández, Rocío Villar-Taibo, Mirian Alejo, et al.
Hepatology (Baltimore, Md.)
|
May 26, 2017
Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis
Agustín Albillos, Javier Zamora, Javier Martínez, et al.
Cardiovascular Drugs and Therapy
|
June 27, 2018
Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study)
Marian Goicoechea, Soledad García de Vinuesa, Borja Quiroga, et al.
Page
of 8